The National Institute for Health and Care Excellence (NICE) issued clinical guidance in 2022 recommending the use of esketamine nasal spray for treatment-resistant depression.

Authors

• Person: Not available Organization: Frontiers in Psychiatry
  The Montreal model: an integrative biomedical-psychedelic ...

Sources

• The Montreal model: an integrative biomedical-psychedelic ... www.frontiersin.org Frontiers in Psychiatry via serper

Referenced by nodes (3)

• treatment-resistant depression concept
• esketamine concept
• National Institute for Health and Care Excellence entity